A market model by GlobalData forecasts the peripheral vascular stent market to be worth $3bn by 2033. Abbott’s vascular business divisional vice president of global clinical affairs Jennifer ...

Peripheral vascular devices are of significant importance in the management and treatment of vascular diseases affecting veins and arteries other than the brain ones. These include stents ...

Some of the leading non-vascular stents companies include Medtronic plc, Glaukos Corporation, Boston Scientific Corporation, ELLA – CS, s.r.o., CONMED Corporation. One of the recent developments in ...

Abbott, Boston Scientific, Medtronic, Biotronik, Terumo Corporation, and B. Braun SE are the leading global coronary stents market companies. These vendors are continuously developing and ...

The role of the vascular ... eluting stents must demonstrate improved clinical end points or cost savings before the use of drug-eluting stents for the treatment of infrapopliteal peripheral ...

The major obstacle for precise selection of patients for venous outflow stenting is the lack of a reliable test to measure a hemodynamically significant stenosis. The key for the physician is to ...

Notable peripheral artery disease treatment companies such as Medtronic, Koninklijke Philips ... the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Peripheral ...